Some doctors have blamed Serevent (salmeterol, also found in Advair) for up to 4,000 asthma-related deaths per year. Though salmeterol is designed to keep life-threatening asthma attacks at bay, studies have found that salmeterol can actually cause such attacks in some patients. GlaxoSmithKline has recently revised product labeling to reflect some risks, but finds the data on asthma-related deaths "inconclusive."
Read moreIn this entry, I would like to discuss some recent findings on two similar medications that have significantly changed the landscape of... Read more »
Last week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory... Read more »
Last month the FDA (Food and Drug Administration) voted unanimously that the benefit of Advair and Symbicort outweighed the risks of... Read more »
Black box warnings are a type of labeling that the Federal Drug Administration (FDA, for short) requires pharmaceutical companies to use... Read more »
In this entry, I would like to discuss the implications of some recently published basic science research on the function of beta agonists... Read more »
A gene variant found in some of the population may be responsible for the lack of effectiveness of salmeterol in some people, a British study has... Read more »
This is a study to measure the asthma control of Flovent (fluticasone propionate) and salmeterol in children and teens whose asthma is worsened by... Read more »
Data from a study comparing Symbicort (budesonide, formoterol), Advair (fluticasone propionate, salmeterol), and salbutamol has found that... Read more »
A new study by drugmaker GlaxoSmithKline has found that Advair (fluticasone propionate, salmeterol) and Flovent (fluticasone propionate) appear to be... Read more »
Salmeterol, a long-acting beta agonist, led to a significant increase in asthma-related deaths, according to a clinical trial funded by... Read more »